The World Health Organization called out China’s lack of transparency over mounting COVID-19 infections. “In the absence of comprehensive information from China, it is understandable that countries around the world are acting in ways that they believe may protect their populations,” WHO Director-General Tedros Adhanom Ghebreyesus tweeted. (Newsweek)
Aslan, Thermo Fisher have teamed up to make eblasakimab, a monoclonal antibody to treat moderate-to-severe atopic dermatitis, for clinical trials. Aslan added that it has developed a high concentration formulation of eblasakimab, allowing up to 400mg eblasakimab to be administered in a single subcutaneous injection and suitable for use with different devices. (Seeking Alpha)
Aurinia Pharma settled its lawsuit with Sun Pharma. The Canadian pharmaceuticals company said the settlement involves filing a joint motion with Sun Pharmaceutical to terminate an inter partes review of an Aurinia patent, as well as to settle patent infringement litigation in the U.S. over Sun Pharamceutical’s Cequa dry-eye treatment. (MarketWatch)
Elon Musk tweeted that he’ll release ‘Fauci Files’ this week. Recently, Musk claimed that former employees of Twitter maintained a Slack channel titled “Fauci Fan Club.” (New York Post)
This biotech founder said he has an innovative plan to treat Tourette Syndrome, which affects 200,000 Americans each year. Jeff Aronin, CEO of Paragon Biosciences and founder of Emalex Biosciences, said clinical trial results for a new medication will be out by 2025. (Business Insider)
